Pitt Vaccine Triggers Immunity to Prevent Colon Cancer
PITTSBURGH, Jan. 7, 2013 – A first-of-its-kind vaccine developed by University of Pittsburgh Cancer Institute (UPCI) researchers successfully prompted the immune system to respond to early indications...
View ArticleAfrican-American Women Less Likely To Receive HPV Vaccine than Whites, Even...
PITTSBURGH, Aug, 27, 2013 – Even with access to health care, African-American women are less likely to receive the vaccine for human papillomavirus (HPV), which reduces the risk for cervical cancer,...
View ArticlePitt Center for Vaccine Research Joins Global Task Force to Address Urgent...
PITTSBURGH, April 7, 2014 – Causing victims to suffer severe fever and pain, chikungunya virus has reached the Caribbean and South America — and is predicted to soon cause outbreaks in the United...
View ArticlePitt CVR and Sanofi Pasteur Collaborate to Assess the Effectiveness of a...
PITTSBURGH, April 15, 2014 – The University of Pittsburgh Center for Vaccine Research (CVR) and Sanofi Pasteur, the vaccines division of Sanofi, have entered a scientific collaboration to help assess...
View ArticlePitt-Developed Vaccine Proves Effective Against Deadly Middle East Virus
PITTSBURGH, Sept. 12, 2014 – A vaccine developed by an international team of scientists led by the University of Pittsburgh School of Medicine successfully protects mice against a contagious and deadly...
View Article
